Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma

Minimally‐invasive tools to assess tumour presence and burden may improve clinical management. FDG‐PET (metabolic) imaging is the current gold standard for interim response assessment in patients with classical Hodgkin Lymphoma (cHL), but this technique cannot be repeated frequently. Here we show th...

Descripción completa

Detalles Bibliográficos
Autores principales: Drees, Esther E. E., Roemer, Margaretha G. M., Groenewegen, Nils J., Perez‐Boza, Jennifer, van Eijndhoven, Monique A. J., Prins, Leah I., Verkuijlen, Sandra A. W. M., Tran, Xuan‐Mai, Driessen, Julia, Zwezerijnen, G. J. C., Stathi, Phylicia, Mol, Kevin, Karregat, Joey J. J. P., Kalantidou, Aikaterini, Vallés‐Martí, Andrea, Molenaar, T. J., Aparicio‐Puerta, Ernesto, van Dijk, Erik, Ylstra, Bauke, Groothuis‐Oudshoorn, Catharina G. M., Hackenberg, Michael, de Jong, Daphne, Zijlstra, Josée M., Pegtel, D. Michiel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282992/
https://www.ncbi.nlm.nih.gov/pubmed/34295456
http://dx.doi.org/10.1002/jev2.12121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282992/
https://www.ncbi.nlm.nih.gov/pubmed/34295456
http://dx.doi.org/10.1002/jev2.12121

Ejemplares similares